We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Study Shows Advantages of New Prostate Cancer Treatment

By HospiMedica International staff writers
Posted on 08 Aug 2017
A new study has shown that brachytherapy treatment of prostate cancer patients using the Cesium-131 Isotope provides a targeted, fast-acting treatment, within a 30-day delivery time, that is significantly better than other isotopes.

While many prostate cancer patients still undergo costly invasive surgery, or long-term radiation treatment, then new brachytherapy treatment could provide a more cost-effective and safer alternative with fewer side effects.

The study was published in the August 1, 2017, issue of the International Journal of Radiation Oncology, Biology and Physics. More...
The researchers evaluated the long-term Quality of Life (QOL) scores reported by patients with prostate cancer, and showed that treatment using the newest brachytherapy isotope, Cesium-131, reduced the QOL and the length of the recovery period. The faster-acting Cesium-131 isotope is made by Isoray Medical (Richmond, WA, USA) and enables patients to recover faster from the radiation side effects, and return to normal bowel, urinary, and sexual function than those treated with other brachytherapy isotopes. Isoray uses a new proprietary process to manufacture the Cesium-131 brachytherapy isotope seeds.

Chicago Prostate Cancer Center medical director, Dr. Brian Moran, said, "For far too long, patients have been treated for prostate cancer based on a medical professionals' familiarity or, in some cases, due to far greater financial benefits to the physician. This study reinforces that a new, patient-friendly treatment exists. Brachytherapy with Cesium-131 leverages the isotope's short half-life to significantly reduce the duration of long-term symptoms and side effects."

Related Links:
Isoray Medical


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Vessel Sealing Instrument
ERGOseal
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.